AXP vs LENZ · P/E 20, rev $21.73B vs rev $7.4M
American Express Company (AXP) versus LENZ Therapeutics Inc (LENZ) — a side-by-side from cached financials, not a winner call.
American Express Company (AXP) is a credit services company listed on US.
LENZ Therapeutics Inc (LENZ) is a biotechnology company listed on US.
Latest reported AXP revenue for 2026-06-30 was $21.73B. Net income was $6.08B. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
Latest reported LENZ revenue for 2026-06-30 was $7.4M. Net income was -$73.4M. LENZ currently screens at market cap $223.6M.
AXP currently screens at market cap $215.94B and trailing P/E 19.8. LENZ currently screens at market cap $223.6M.
Not investment advice. Open the AXP and LENZ stock pages for the full models.
Not investment advice.